R. G. Wiewrodt (Muenster, Germany), M. Skrzypski (Sopot, Poland)
Simvastatin overcomes gefitinib resistance in non-small cell lung cancer with the T790M mutation of epidermal growth factor receptor via Akt/b-catenin signaling dependent down-regulation of survivin H. R. Kim, K. E. Hwang, E. T. Jeong (Iksan, Republic Of Korea)
|  |
Histone deacetylase inhibitor panobinostat reduces hypoxia-related cisplatin resistance in NSCLC cells by HDAC-mediated Hifalpha destabilization C. Fischer, K. Leithner, C. Wohlkoenig, E. Stacher, A. Olschewski, H. Olschewski, A. Hrzenjak (Graz, Austria)
|   |
Neurotrophin TrkB receptor mediates the epithelial to mesenchymal transition in lung adenocarcinoma cells A. Ricci, L. Tabbì, D. Scozzi, R. Mancini, C. De Vitis, P. Bruno, S. Mariotta (Rome, Italy)
|  |
Role of insulin and IGF-1 receptors in bronchial epithelial cancer cells C. Frisch, A. Harst, K. Zimmermann, A. Pfeifer, P. Mayer, K. Racké (Bonn, Germany)
|   |
Regulatory T, B cells and inflammation: Do they play an important role in lung cancer? J. Zhou, Z. Min, Y. Song, C. Bai, X. Wang (Shanghai, China)
|  |
Possible role of nuclear receptor nr4a1 in hypoxia-induced cisplatin resistance C. Wohlkoenig, K. Leithner, A. Hrzenjak, A. Olschewski, H. Olschewski (Graz, Austria)
|  |
Aromatase inhibition alters the mechanical properties of non small-cell lung cancer cells affecting cell movement E. Giannopoulou, I. Kritikou, D. Metsiou, G. Athanassiou, H. P. Kalofonos (Rion, Patras, Greece)
|   |
The active compound of garlic to treat non-small cell lung cancer: in vitro studies Y. Schwarz, L. Kindil, A. Bar-Shai, A. Rabinkov, A. Star (Tel-Aviv, Rehovot, Israel)
|   |
Proapoptotic effects of PAI-1 protein on lung and prostate cancer cells A. Rozy, M. Kedzior, J. Chorostowska-Wynimko, A. Szpechcinski, E. Skrzypczak-Jankun, J. Jankun (Warsaw, Poland; Toledo, United States Of America)
|   |
Inhibition of human lung H460 cell proliferation by siRNA-mediated macrophage migration inhibitory factor (MIF) blocking W. Tan, Y. Luo, J. Hou, H. Yang, Y. Guo (Guangzhou, China)
|  |
Development of an invasive 3D lung tumor model for oncological research D. Fecher, H. Walles, T. Walles, S. Nietzer, G. Dandekar (Wuerzburg, Germany)
|   |
Glucocorticoid reduces pemetrexed sensitivity by mediating senescence-associated secretory phenotype in Bcl-2 dependent manner in non-small-cell lung cancer H. Ge, S. Ni, J. Ou, X. Fang, Y. Song, C. Bai (Shanghai, China)
|  |
Investigate which PKC isoform play an important role in human lung cancer cells against TRAIL-induced apoptosis C. C. Tu, W. J. Wu (Taichung, Taiwan)
|  |
Roles of polarized neutrophils on lung tumour development in an orthotopic lung tumour mouse model N. Rocks, S. Bekaert, G. Warnock, C. Sepult, R. Marée, J. M. Foidart, A. Noël, D. Cataldo (Liege, Belgium)
|   |
Real-time molecular imaging of EGFR mutations using fibred confocal fluorescence microscopy (FCFM) M. Patout, M. Salaun, P. Bohn, X. Brune, A. Romieu, N. Vasseur, R. Sesboüé, P. Y. Renard, L. Thiberville (Rouen, Mont-Saint-Aignan, France)
|   |
Ghrelin ameliorates cachectic status in the mouse model of lung cancer model H. Tsubouchi, S. Yanagi, N. Matsumoto, M. Nakazato (Miyazaki-shi, Japan)
|  |
Promotion of lung cancer progression by COPD-like chronic inflammation in a mouse model F. Liu, Q. Hong, C. Bai (Shanghai, China)
|  |
The potential role of the pequi fruit (caryocar braziliense camb) in the prevention of lung cancer in an experimental model N. B. R. Colombo, E. R. Parra, C. K. Grisolia, M. Hage, D. Barbeiro, V. L. Capelozzi (São Paulo, Brasilia, Brazil)
|  |